However, given the benefits of deleting HMOX1 in hepatocytes from mice with steatosis, bilirubin could be an example of a maladaptive antioxidant promoting NAFLD and insulin resistance. Here, HMOX1 is linked to metabolic dysfunction-associated steatotic liver disease.